Search results
Results from the WOW.Com Content Network
The thrombosis events associated with the COVID‑19 vaccine may occur 4–28 days after its administration and mainly affects women under 55. [6] [2] [20] Several relatively unusual types of thrombosis were specifically reported to be occurring in those with the reaction: cerebral venous sinus thrombosis and thrombosis of the splanchnic veins.
New COVID vaccines are here. What to know about 2024–25 shots as summer surge continues What to know about 2024–25 shots as summer surge continues COVID can cause mental illness —but being ...
COVID-19 increases the risk of heart attack and stroke years after infection, a new study finds. ... Given that there is a high population immunity to COVID-19, from vaccines and natural infection ...
Experts say the best way to prevent a COVID-19-related cardiac event is to receive an updated vaccine to protect against severe illness. Amid the recent rollout of updated COVID-19 vaccines, a new ...
However, loss of olfaction is not unique to COVID-19; approximately 13% of patients with influenza also lose olfaction, as do patients with MERS-CoV and Ebola virus. [11] Among the patients with COVID-19, 50% of patients recover olfaction within 14 days, and 89% of patients have complete resolution of their loss of olfaction within 4 weeks.
A study on the effectiveness of a first dose of the Pfizer–BioNTech or Oxford–AstraZeneca COVID-19 vaccines against COVID-19 related hospitalisation in Scotland was based on a national prospective cohort study of 5.4 million people. Between 8 December 2020 and 15 February 2021, 1,137,775 participants were vaccinated in the study, 490,000 of ...
People who were diagnosed with severe COVID-19 infections from the first wave of the pandemic could face double the risk of heart attack and stroke, a new study has found. Researchers focused on ...
In March 2021, the European Medicines Agency (EMA) announced that out of the around 20 million people who had received the Oxford–AstraZeneca COVID-19 vaccine, general blood clotting rates were normal, but that it had identified seven cases of disseminated intravascular coagulation, and eighteen cases of cerebral venous sinus thrombosis. [35]